George Rofaiel, MD
Transplant Surgery · Allentown, PANPI 1265622138
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,230 of the $1,888 with a category attached, or 65.2%. Intuitive Surgical accounts for 70.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $1,331 and has fallen 76.2% since, to $317 in 2024.
Across 14 payments — averaging $134.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Merck$128
- Takeda Pharmaceuticals U.S.A., Inc.$125
- Sanofi-aventis U.S. LLC$100
- Medtronic$85
- Veloxis Pharmaceuticals, Inc.$82
- plus $42 from 2 others
What the payments were for
- Travel & lodging$1,23065%
- Food & beverage$52828%
- Education$1307%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 4 | $1,327 |
| Merck | 2 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Medtronic | 1 | $85 |
| Veloxis Pharmaceuticals, Inc. | 2 | $82 |
| AbbVie | 1 | $23 |
| Dynavax Technologies Corporation | 2 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,211
- LIVTENCITY$125
- PREVYMIS$107
- THYMOGLOBULIN$100
How this compares
$1,888 in reported general payments places this provider in the 65th percentile of 41 transplant surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 112 | $27,519 |
| EliquisApixaban | 18 | $17,431 |
| Mycophenolic AcidMycophenolate Sodium | 32 | $9,395 |
| Tacrolimus | 26 | $6,195 |
| Nystatin | 72 | $2,411 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 186 | $921 |
| Prednisone | 67 | $505 |
| Tamsulosin Hcl | 19 | $441 |
| Dapsone | 12 | $439 |
| Acyclovir | 21 | $185 |
| Famotidine | 47 | $164 |
| Pantoprazole Sodium | 13 | $103 |
| Furosemide | 17 | $36 |
| Metoprolol Succinate | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Allentown
- Christine duAllentown$3K
- Patty LiuAllentown$570
- Michael MoritzAllentown$427
- Brian ChenAllentown$85
- Pradip ChakrabartiAllentown$48
- Michael MarvinDanville$143K
- Adam BodzinPhiladelphia$75K
- Peter AbtPhiladelphia$10K
- Anil KotruDanville$8K
- Ira FoxPittsburgh$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.